By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter said after the close of the market Thursday that its board of directors has declared a quarterly dividend of $.18 per share.

The dividend is payable on March 12 to all shareholders of record on Feb. 26. It noted that the dividend marks the 85th consecutive quarterly cash dividend payout.

Beckman Coulter also said that its board has authorized the repurchase of up to 1.5 million shares of the firm's outstanding common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.